261 related articles for article (PubMed ID: 24461904)
21. [Infectious complication after lung transplantation for cystic fibrosis].
Hérault E; Vaissier E; Lenoir G; Sors H; Gibert C; Silly C; Bisson A; Couetil JC; Cabrol C; Gandjbakhch I
Rev Mal Respir; 1995; 12(1):43-8. PubMed ID: 7899666
[TBL] [Abstract][Full Text] [Related]
22. Lung transplantation in cystic fibrosis.
Egan TM
Semin Respir Infect; 1992 Sep; 7(3):227-39. PubMed ID: 1475546
[TBL] [Abstract][Full Text] [Related]
23. Burkholderia pyrrocinia in cystic fibrosis lung transplantation: a case report.
Savi D; De Biase RV; Amaddeo A; Anile M; Venuta F; Ruberto F; Simmonds N; Cimino G; Quattrucci S
Transplant Proc; 2014; 46(1):295-7. PubMed ID: 24507071
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
[TBL] [Abstract][Full Text] [Related]
25. Infectious complications of lung transplantation. Impact of cystic fibrosis.
Flume PA; Egan TM; Paradowski LJ; Detterbeck FC; Thompson JT; Yankaskas JR
Am J Respir Crit Care Med; 1994 Jun; 149(6):1601-7. PubMed ID: 7516251
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?
Smyth A
Pediatr Pulmonol; 2005 Dec; 40(6):471-6. PubMed ID: 16200640
[TBL] [Abstract][Full Text] [Related]
27. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population.
Qvist T; Pressler T; Thomsen VO; Skov M; Iversen M; Katzenstein TL
Transplant Proc; 2013; 45(1):342-5. PubMed ID: 23267788
[TBL] [Abstract][Full Text] [Related]
28. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.
Lechtzin N; John M; Irizarry R; Merlo C; Diette GB; Boyle MP
Respiration; 2006; 73(1):27-33. PubMed ID: 16113513
[TBL] [Abstract][Full Text] [Related]
30. Respiratory bacterial infections in cystic fibrosis.
Ciofu O; Hansen CR; Høiby N
Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
[TBL] [Abstract][Full Text] [Related]
31. [New advances in the management and treatment of cystic fibrosis].
Mihălţan F
Pneumologia; 2014; 63(1):21-5. PubMed ID: 24800591
[TBL] [Abstract][Full Text] [Related]
32. Lung transplant for a patient with cystic fibrosis and active Burkholderia Cenocepacia pneumonia.
Salizzoni S; Pilewski J; Toyoda Y
Exp Clin Transplant; 2014 Oct; 12(5):487-9. PubMed ID: 25299375
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?
Cullen AR; Cannon CL; Mark EJ; Colin AA
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):641-5. PubMed ID: 10673211
[TBL] [Abstract][Full Text] [Related]
34. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center.
Aitken ML; Limaye A; Pottinger P; Whimbey E; Goss CH; Tonelli MR; Cangelosi GA; Dirac MA; Olivier KN; Brown-Elliott BA; McNulty S; Wallace RJ
Am J Respir Crit Care Med; 2012 Jan; 185(2):231-2. PubMed ID: 22246710
[No Abstract] [Full Text] [Related]
35. Successful lung transplant in a child with cystic fibrosis and persistent Blastobotrys rhaffinosifermentans infection.
Wong JY; Chambers AL; Fuller J; Lacson A; Mullen J; Lien D; Humar A
Pediatr Transplant; 2014 Aug; 18(5):E169-73. PubMed ID: 24930454
[TBL] [Abstract][Full Text] [Related]
36. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
Saiman L; Siegel J;
Am J Infect Control; 2003 May; 31(3 Suppl):S1-62. PubMed ID: 12762292
[No Abstract] [Full Text] [Related]
37. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
[TBL] [Abstract][Full Text] [Related]
38. Assessment of infection risks prior to lung transplantation.
Luong ML; Morrissey O; Husain S
Curr Opin Infect Dis; 2010 Dec; 23(6):578-83. PubMed ID: 20847696
[TBL] [Abstract][Full Text] [Related]
39. Aerosolized vancomycin for the treatment of MRSA after lung transplantation.
Hayes D; Murphy BS; Mullett TW; Feola DJ
Respirology; 2010 Jan; 15(1):184-6. PubMed ID: 19895389
[TBL] [Abstract][Full Text] [Related]
40. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
